Celltrion Investor Relations Material
Latest events
Investor Day 2024
Celltrion
Q1 2025
9 May, 2025
Q4 2024
16 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celltrion Inc
Access all reports
Celltrion Inc. is a South Korea-based biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company focuses on monoclonal antibodies, biosimilars, and innovative biologic therapies for various medical conditions. Celltrion operates state-of-the-art biopharmaceutical production facilities and engages in global partnerships for the commercialization of its products. The company is headquartered in Incheon, South Korea, and its shares are listed on the KRX.
Key slides for Celltrion Inc
Investor Presentation
Celltrion Inc
Investor Presentation
Celltrion Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
A068270
Country
🇰🇷 South Korea